Japan’s precision medicine ambitions are again being supported by a new partnership between Oxford Nanopore Technologies and A. D. A. M. Innovations. The two companies today announced the signing of a strategic partnership agreement to jointly promote genomic medicine in Japan. Through this partnership, the two companies desire to support the goal of the Japanese Government to use next generation sequencing technologies clinically, allowing doctors to make diagnoses more rapidly and accurately, and to customize treatment plans to individual patients.<\/p>
\u4eca\u56de\u306e\u63d0\u643a\u306f\u3001\u30aa\u30c3\u30af\u30b9\u30d5\u30a9\u30fc\u30c9\u30fb\u30ca\u30ce\u30dd\u30a2\u306e\u30e9\u30a4\u30d6\u30b7\u30fc\u30b1\u30f3\u30b9\u6280\u8853\u3092\u3001\u65e5\u672c\u306eA.D.A.M.\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ba\u306e\u907a\u4f1d\u5b50\u691c\u67fb\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u5c0e\u5165\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u3053\u306e\u624b\u6cd5\u306b\u3088\u308a\u3001\u69d8\u3005\u306a\u9577\u3055\u306eDNA\u3092\u975e\u5e38\u306b\u9ad8\u3044\u7cbe\u5ea6\u3067\u30b7\u30fc\u30b1\u30f3\u30b9\u3059\u308b\u306a\u3069\u3001\u8a73\u7d30\u306a\u30b2\u30ce\u30e0\u89e3\u6790\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002.<\/p>
In contrast to traditional sequencing methods, nanopore-based technologies not only give data instantly but also produce more detailed datasets which help doctors identify genetic changes more efficiently. The project intends to create new clinical workflows compliant with Japan’s regulations so these high-tech functions could be used widely in healthcare facilities.<\/p>
\u691c\u67fb\u306e\u7cbe\u5ea6\u3092\u5411\u4e0a\u3055\u305b\u3001\u8a3a\u65ad\u306e\u65b0\u305f\u306a\u53ef\u80fd\u6027\u3092\u958b\u304f\u3053\u3068\u304c\u3001\u975e\u5e38\u306b\u307e\u308c\u306a\u907a\u4f1d\u6027\u75be\u60a3\u304b\u3089\u975e\u5e38\u306b\u8907\u96d1\u306a\u6162\u6027\u75be\u60a3\u307e\u3067\u3001\u591a\u7a2e\u591a\u69d8\u306a\u75be\u60a3\u3092\u5bfe\u8c61\u3068\u3059\u308b\u3053\u306e\u5354\u5b9a\u306e\u6839\u62e0\u3067\u3059\u3002.<\/p>
\u3053\u306e\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306f\u3001\u82f1\u56fd\u3068\u65e5\u672c\u306e\u79d1\u5b66\u4ea4\u6d41\u306e\u5168\u4f53\u7684\u306a\u5f37\u5316\u306e\u4e00\u4f8b\u3067\u3059\u3002\u3053\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u9769\u65b0\u3068\u30b2\u30ce\u30e0\u7814\u7a76\u3092\u4fc3\u9032\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u305f\u4e8c\u56fd\u9593\u5354\u5b9a\u306b\u6cbf\u3063\u305f\u3082\u306e\u3067\u3059\u3002.<\/p>
\u82f1\u56fd\u306e\u6280\u8853\u30ce\u30a6\u30cf\u30a6\u3068\u65e5\u672c\u306e\u4e00\u6d41\u306e\u81e8\u5e8a\u30fb\u7814\u7a76\u65bd\u8a2d\u3092\u7d71\u5408\u3057\u305f\u3053\u306e\u5171\u540c\u4e8b\u696d\u306f\u3001\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30fb\u30e1\u30c7\u30a3\u30b7\u30f3\u306e\u5275\u51fa\u30d7\u30ed\u30bb\u30b9\u3092\u52a0\u901f\u3055\u305b\u308b\u305f\u3081\u306e\u7d20\u6674\u3089\u3057\u3044\u821e\u53f0\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u4e16\u754c\u7684\u306a\u533b\u7642\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u30b2\u30ce\u30df\u30af\u30b9\u306e\u5c0e\u5165\u3092\u3055\u3089\u306b\u4fc3\u9032\u3059\u308b\u591a\u56fd\u9593\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306e\u53ef\u80fd\u6027\u306b\u3082\u9053\u3092\u958b\u304f\u3082\u306e\u3067\u3059\u3002.<\/p>
\u3053\u306e\u3088\u3046\u306a\u56fd\u969b\u5354\u529b\u306f\u3001\u5404\u56fd\u304c\u6700\u3082\u56f0\u96e3\u306a\u5065\u5eb7\u554f\u984c\u306b\u5bfe\u51e6\u3059\u308b\u305f\u3081\u306b\u3001\u305d\u308c\u305e\u308c\u306e\u30ea\u30bd\u30fc\u30b9\u3084\u30ce\u30a6\u30cf\u30a6\u3092\u7d50\u96c6\u3055\u305b\u305f\u3044\u3068\u8003\u3048\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u3001\u91cd\u8981\u6027\u3092\u5897\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>
\u3053\u306e\u5171\u540c\u7814\u7a76\u306e\u4e3b\u306a\u76ee\u7684\u306f\u3001\u3088\u308a\u5e83\u7bc4\u306a\u30b2\u30ce\u30e0\u691c\u67fb\u3092\u5b9f\u65bd\u3059\u308b\u3053\u3068\u3067\u3001\u65e9\u671f\u8a3a\u65ad\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u3067\u3059\u3002\u5f93\u6765\u306e\u8a3a\u65ad\u65b9\u6cd5\u306f\u3001\u4e00\u822c\u7684\u306b\u69d8\u3005\u306a\u7a2e\u985e\u306e\u691c\u67fb\u306b\u4f9d\u5b58\u3057\u3066\u304a\u308a\u3001\u305d\u306e\u7d50\u679c\u3001\u75be\u60a3\u306e\u6b63\u78ba\u306a\u7279\u5b9a\u304c\u9045\u308c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>
Combining all these methods into one single, data-heavy sequencing process, the team behind this project hope to simplify the diagnosis procedures and reduce the time it takes to initiate treatment. This is even more crucial with the case of rare diseases since early detection can significantly change the patient’s prognosis.<\/p>
Simultaneously, this new ability to get comprehensive genomic data presents further opportunities for personalized medicine, which means that therapies can be tailored to an individual’s genetic profile.<\/p>
The partnership is expected to revolutionize the healthcare and biotechnology sectors in Japan. With the cost of genome sequencing technology decreasing and becoming more accessible, medical institutions, scientific institutions, and biopharmaceutical companies will be presented with the opportunity to use high-level sequencing in their operations. By opening up such an opportunity, Japan will be contributing to its quest of fully embracing the precision medicine model, whereby data-driven information will be the main aspect in the diagnosis and treatment of diseases. In addition, the partnership will lead to Japan’s consolidation of its position as one of the world leaders in life sciences innovation, in areas where genomics, AI, and clinical research intersect.<\/p>
\u4e21\u793e\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u306b\u304a\u3044\u3066\u5e83\u304f\u7d71\u5408\u3055\u308c\u305f\u30a4\u30f3\u30d5\u30e9\u30b9\u30c8\u30e9\u30af\u30c1\u30e3\u30fc\u3092\u69cb\u7bc9\u3059\u308b\u3053\u3068\u3067\u3001\u4e16\u754c\u4e2d\u306e\u60a3\u8005\u3055\u3093\u3078\u306e\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3068\u63d0\u4f9b\u3092\u52a0\u901f\u3057\u3001\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u7523\u696d\u304c\u30b0\u30ed\u30fc\u30d0\u30eb\u5316\u3068\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u6ce2\u306b\u4e57\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u307e\u3059\u3002\u4e21\u793e\u306f\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u65b0\u85ac\u306e\u4e0a\u5e02\u6570\u3092\u500d\u5897\u3055\u305b\u3001\u60a3\u8005\u3055\u3093\u306e\u65b0\u85ac\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u5411\u4e0a\u3055\u305b\u308b\u305f\u3081\u3001\u5354\u529b\u3057\u3066\u65e5\u672c\u306e\u533b\u85ac\u54c1\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u306b\u304a\u3051\u308b\u8ab2\u984c\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u304d\u307e\u3059\u3002.<\/p>
\u4e21\u793e\u306e\u76ee\u6a19\u306f\u3001\u4e21\u793e\u306e\u4e8b\u696d\u306e\u9577\u6240\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u60a3\u8005\u3001\u533b\u7642\u5f93\u4e8b\u8005\u3001\u305d\u3057\u3066\u793e\u4f1a\u5168\u4f53\u306b\u5229\u76ca\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u306e\u3042\u308b\u4fa1\u5024\u3092\u5171\u5275\u3059\u308b\u3053\u3068\u3067\u3059\u3002.<\/p>
\u30d8\u30eb\u30b9\u30b1\u30a2\u3084\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u3067\u4e8b\u696d\u3092\u5c55\u958b\u3059\u308b\u4f01\u696d\u3067\u3042\u308c\u3070\u3001\u3053\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u62e1\u5f35\u6027\u304c\u3042\u308a\u6280\u8853\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u30b2\u30ce\u30e0\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u65b9\u5411\u6027\u304c\u5909\u308f\u308b\u3053\u3068\u3092\u793a\u3059\u826f\u3044\u30b7\u30b0\u30ca\u30eb\u3067\u3059\u3002\u30cf\u30a4\u30a8\u30f3\u30c9\u306e\u30b7\u30fc\u30b1\u30f3\u30b9\u6280\u8853\u3092\u7d71\u5408\u3057\u305f\u4f01\u696d\u304c\u512a\u4f4d\u306b\u7acb\u3064\u3067\u3057\u3087\u3046\u3002.<\/p>
\u3053\u306e\u53d6\u5f15\u306f\u3001\u30b2\u30ce\u30e0\u30c7\u30fc\u30bf\u3092\u5927\u898f\u6a21\u306b\u51e6\u7406\u3067\u304d\u308b\u65bd\u8a2d\u306e\u5fc5\u8981\u6027\u304c\u9ad8\u307e\u3063\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u3059\u3082\u306e\u3067\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u65bd\u8a2d\u306f\u3001\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001AI\u30d9\u30fc\u30b9\u306e\u5206\u6790\u3001\u30c7\u30fc\u30bf\u7ba1\u7406\u30b7\u30b9\u30c6\u30e0\u306b\u56f2\u307e\u308c\u3066\u3044\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>
\u3055\u3089\u306b\u3001\u3053\u306e\u5236\u5ea6\u306f\u65e5\u672c\u306e\u30b2\u30ce\u30df\u30af\u30b9\u30fb\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u6295\u8cc7\u306b\u5f3e\u307f\u3092\u3064\u3051\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u306e\u5236\u5ea6\u306f\u3001\u62e1\u5927\u3059\u308b\u7cbe\u5bc6\u533b\u85ac\u54c1\u5e02\u5834\u306e\u6a5f\u4f1a\u3092\u6349\u3048\u3088\u3046\u3068\u3059\u308b\u56fd\u5185\u5916\u306e\u30d7\u30ec\u30fc\u30e4\u30fc\u3092\u60f9\u304d\u3064\u3051\u308b\u3053\u3068\u3067\u3057\u3087\u3046\u3002.<\/p>
A.D.A.M.\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30ba\u3001\u30aa\u30c3\u30af\u30b9\u30d5\u30a9\u30fc\u30c9\u30fb\u30ca\u30ce\u30dd\u30a2\u793e\u3068\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u533b\u7642\u6280\u8853\u3060\u3051\u3067\u306a\u304f\u3001\u305d\u306e\u5b9f\u8df5\u306e\u5927\u304d\u306a\u6307\u6a19\u3067\u3059\u3002\u5f7c\u3089\u306f\u3001\u500b\u4eba\u306e\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u5305\u62ec\u7684\u306a\u30b2\u30ce\u30e0\u89e3\u6790\u3092\u5c0e\u5165\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u3046\u3057\u3066\u3001\u533b\u7642\u306f\u53cd\u5fdc\u7684\u306a\u3082\u306e\u304b\u3089\u3001\u3088\u308a\u7a4d\u6975\u7684\u3067\u500b\u5225\u5316\u3055\u308c\u305f\u30e2\u30c7\u30eb\u3078\u3068\u79fb\u884c\u3057\u3066\u3044\u304f\u3067\u3057\u3087\u3046\u3002.<\/p>
\u666e\u53ca\u304c\u9032\u3081\u3070\u3001\u3053\u306e\u7a2e\u306e\u6280\u8853\u306f\u304a\u305d\u3089\u304f\u3001\u5275\u85ac\u3001\u75be\u75c5\u4e88\u9632\u3001\u96c6\u56e3\u5065\u5eb7\u7ba1\u7406\u306a\u3069\u3001\u8a3a\u65ad\u306b\u3068\u3069\u307e\u3089\u306a\u3044\u5206\u91ce\u306b\u5e83\u304c\u3063\u3066\u3044\u304f\u3067\u3057\u3087\u3046\u3002.<\/p>
The collaboration between Oxford Nanopore Technologies and A. D. A. M. Innovations stands out as a significant step in the development of genomic medicine in Japan. By bringing together the advanced sequencing capabilities with the thorough understanding of the local context, this project aims to greatly speed up the country’s transition to the use of precision healthcare.<\/p>
\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u5909\u9769\u304c\u9032\u3080\u4e2d\u3001\u4eca\u56de\u306e\u3088\u3046\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u672a\u6765\u306b\u3064\u3044\u3066\u306e\u8003\u3048\u65b9\u3092\u5909\u3048\u308b\u3060\u3051\u3067\u306a\u304f\u3001\u5b9f\u969b\u306b\u5f79\u7acb\u3064\u3082\u306e\u3067\u3059\u3002\u3064\u307e\u308a\u3001\u30c7\u30fc\u30bf\u306e\u304a\u304b\u3052\u3067\u3001\u500b\u5225\u5316\u533b\u7642\u304c\u73cd\u3057\u3044\u3082\u306e\u3067\u306f\u306a\u304f\u3001\u65b0\u3057\u3044\u666e\u901a\u3068\u306a\u308b\u672a\u6765\u3067\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"
Japan’s precision medicine ambitions are again being supported by a new partnership between Oxford Nanopore Technologies and A. D. A. M. Innovations. The two companies today announced the signing of a strategic partnership agreement to jointly promote genomic medicine in Japan. Through this partnership, the two companies desire to support the goal of the Japanese Government to use next generation sequencing technologies clinically, allowing doctors to make diagnoses more rapidly and accurately, and to customize treatment plans to individual patients.Advancing Next-Generation Genomic CapabilitiesThe collaboration is about implementing Oxford Nanopores live sequencing technology within the genetic testing platforms of A. D. A. M. Innovations in Japan. This method makes it possible […]<\/p>\n","protected":false},"author":7,"featured_media":30168,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[181,89,8098],"tags":[8281,150,11998,12062,11999],"ppma_author":[572],"class_list":["post-30144","post","type-post","status-publish","format-standard","has-post-thumbnail","category-biotech","category-health-tech","category-news-articles","tag-a-d-a-m-innovations","tag-biotech","tag-genomic-medicine","tag-healthcare-tech","tag-oxford-nanopore"],"yoast_head":"\n